Patents by Inventor Kurt Steinar Tande

Kurt Steinar Tande has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10485779
    Abstract: This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.
    Type: Grant
    Filed: December 27, 2013
    Date of Patent: November 26, 2019
    Assignee: Calanus AS
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande
  • Patent number: 9820958
    Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: November 21, 2017
    Assignee: Calanus AS
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande
  • Patent number: 9271477
    Abstract: The present invention relates to a device for isolating farm cages for fish against undesirable organisms, which device is arranged enclosing the farm cage, where the device comprises a fine-meshed fluid-permeable net which is open upwardly and downwardly when arranged round the farm cage, where the fluid-permeable net will extend a distance down in the farm cage's depth direction, in order thereby to form a skirt round the farm cage.
    Type: Grant
    Filed: February 12, 2013
    Date of Patent: March 1, 2016
    Assignee: Calanus AS
    Inventors: Snorre Angell, Remi Mathisen, Bjarne Johansen, Trond Larsen, Kurt Steinar Tande
  • Publication number: 20150000606
    Abstract: The present invention relates to a device for isolating farm cages for fish against undesirable organisms, which device is arranged enclosing the farm cage, where the device comprises a fine-meshed fluid-permeable net which is open upwardly and downwardly when arranged round the farm cage, where the fluid-permeable net will extend a distance down in the farm cage's depth direction, in order thereby to form a skirt round the farm cage.
    Type: Application
    Filed: February 12, 2013
    Publication date: January 1, 2015
    Applicant: CALANUS AS
    Inventors: Snorre Angell, Remi Mathisen, Bjarne Johansen, Trond Larsen, Kurt Steinar Tande
  • Publication number: 20140302128
    Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.
    Type: Application
    Filed: June 16, 2014
    Publication date: October 9, 2014
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande
  • Publication number: 20140105999
    Abstract: This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.
    Type: Application
    Filed: December 27, 2013
    Publication date: April 17, 2014
    Applicant: Calanus AS
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande
  • Publication number: 20120136053
    Abstract: This invention relates to an oil composition, preferably obtained from a copepod, and the use thereof to reduce accumulation of visceral fat and counteract impairment of heart function caused by obesity inducing Western diets. The oil composition of the present invention can thus be used to reduce abdominal obesity and improve glucose tolerance and thus to reduce the risk of obesity related diseases such as but not limited to type 2 diabetes or cardiovascular disease, or to prevent or treat such diseases.
    Type: Application
    Filed: June 11, 2010
    Publication date: May 31, 2012
    Applicant: CALANUS AS
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande
  • Publication number: 20110251276
    Abstract: This invention relates to a biological oil composition, preferably obtained from a copepod, most preferably the copepod Calanus finmarchicus and the use thereof to prevent or treat formation of atherosclerotic plaques and hence development of coronary heart disease. The composition comprises the same marine n-3 polyunsaturated fatty acids (PUFAs) generally regarded as being responsible for the anti-atherosclerotic effect of marine oils, namely EPA (C20:5n-3 eicosapentaenoic acid) and DHA (C22:6n-3 docosahexaenoic acid). However, quite unexpectedly, it has been found that the oil composition of the present invention has a remarkably higher ability to prevent formation of atherosclerotic plaques than what can be attributed to EPA and DHA alone, and moreover, unlike EPA and DHA alone it has a notable blood cholesterol lowering effect.
    Type: Application
    Filed: January 4, 2010
    Publication date: October 13, 2011
    Applicant: CALANUS AS
    Inventors: Jan Raa, Gunnar Rorstad, Kurt Steinar Tande